Pharmaceutical

A comprehensive guide to supply chain management for sp...

Integrating sustainable solutions within supply chains is imperative to ensure l...

Rafael Holdings and Cyclo Therapeutics enter merger deal

Rafael Holdings has signed a definitive merger agreement with Cyclo Therapeutics...

VION Biosciences acquires Echelon Biosciences

VION Biosciences has announced the acquisition of Echelon Biosciences, known for...

FDA approves updated mRNA vaccines for Covid-19

The US FDA has approved and granted EUA for Moderna and Pfizer-BioNTech’s update...

Aquestive Therapeutics gets grant for enhanced pharmace...

Discover how Aquestive Therapeutics' new patent enhances epinephrine delivery th...

Acorda Therapeutics gets grant for sustained release 4-...

Discover Acorda Therapeutics' innovative patent for sustained release 4-aminopyr...

Lyra Therapeutics gets grant for coated scaffold for tr...

Discover Lyra Therapeutics' patented coated scaffold for chronic sinusitis treat...

Verve Therapeutics gets grant for gene editing composit...

Discover how Verve Therapeutics' new patent for gene editing targeting the PCSK9...

Frequency Therapeutics gets grant for oligonucleotide c...

Discover Frequency Therapeutics' groundbreaking patent for oligonucleotide thera...

Codiak BioSciences gets grant for extracellular vesicle...

Discover Codiak BioSciences' groundbreaking patent on engineered extracellular v...

OptiBiotix Health gets grant for modified prebiotic oli...

Discover how OptiBiotix Health's new patent for modified prebiotic oligosacchari...

Orion gets grant for cyp11a1 inhibitors for treating pr...

Discover Orion Corp's groundbreaking patent for novel compounds targeting CYP11A...

Ocular Therapeutix gets grant for intracanalicular inje...

Discover Ocular Therapeutix's patented intracanalicular injectable device, desig...

Novartis and Versant launch Borealis Biosciences with $...

Novartis has partnered with Versant Ventures to establish Borealis Biosciences, ...

J&Js Rybrevant plus Lazcluze combination gets FDA appro...

J&J said the drug combination is now the first and only multitargeted, chemother...

ReAlta secures FDA orphan drug and fast track designati...

ReAlta’s pegtarazimod is being developed to treat acute graft-versus-host diseas...